Supramolecular Shear-Thinning Glycopeptide Hydrogels for Injectable Enzyme Prodrug Therapy Applications

Transplantable catalytic reactors have attracted considerable attention as therapeutic biomedical materials. However, existing transplantable reactors such as biocatalytic films are limited by their invasiveness. Here, we report the fabrication of biocatalytic supramolecular hydrogels via self-assem...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 38(2022), 18 vom: 10. Mai, Seite 5883-5890
1. Verfasser: Sakamoto, Yusuke (VerfasserIn)
Weitere Verfasser: Suehiro, Fumi, Akiba, Isamu, Nishimura, Tomoki
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Biocompatible Materials Glycopeptides Hydrogels Prodrugs
LEADER 01000naa a22002652 4500
001 NLM34000973X
003 DE-627
005 20231226004158.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.2c00504  |2 doi 
028 5 2 |a pubmed24n1133.xml 
035 |a (DE-627)NLM34000973X 
035 |a (NLM)35471982 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sakamoto, Yusuke  |e verfasserin  |4 aut 
245 1 0 |a Supramolecular Shear-Thinning Glycopeptide Hydrogels for Injectable Enzyme Prodrug Therapy Applications 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.05.2022 
500 |a Date Revised 05.07.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Transplantable catalytic reactors have attracted considerable attention as therapeutic biomedical materials. However, existing transplantable reactors such as biocatalytic films are limited by their invasiveness. Here, we report the fabrication of biocatalytic supramolecular hydrogels via self-assembly of amphiphilic glycopeptides. We show that the hydrogels have shear-thinning properties, demonstrating their potential to be administered using a syringe. Enzymes can be loaded into the hydrogels by simply adding enzyme solution, and the enzyme-loaded hydrogels can transform a prodrug into an anticancer drug that inhibits tumor cell growth. This study demonstrates the potential of these biocatalytic hydrogels as injectable therapeutic reactors for enzyme prodrug therapy 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Biocompatible Materials  |2 NLM 
650 7 |a Glycopeptides  |2 NLM 
650 7 |a Hydrogels  |2 NLM 
650 7 |a Prodrugs  |2 NLM 
700 1 |a Suehiro, Fumi  |e verfasserin  |4 aut 
700 1 |a Akiba, Isamu  |e verfasserin  |4 aut 
700 1 |a Nishimura, Tomoki  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 38(2022), 18 vom: 10. Mai, Seite 5883-5890  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:38  |g year:2022  |g number:18  |g day:10  |g month:05  |g pages:5883-5890 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.2c00504  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 38  |j 2022  |e 18  |b 10  |c 05  |h 5883-5890